AIG vs COLL · P/E 21, rev $7.18B vs P/E 17, rev $181.9M
American International Group Inc (AIG) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AIG revenue for 2024-12-31 was $7.18B. Net income was $901.0M. Revenue was up 6.3% from 2024-09-30 to 2024-12-31. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the AIG and COLL stock pages for the full models.
Not investment advice.